Catherine A. Koss

2.1k total citations
41 papers, 998 citations indexed

About

Catherine A. Koss is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Catherine A. Koss has authored 41 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 18 papers in Epidemiology and 16 papers in Virology. Recurrent topics in Catherine A. Koss's work include HIV/AIDS Research and Interventions (29 papers), HIV Research and Treatment (16 papers) and HIV, Drug Use, Sexual Risk (12 papers). Catherine A. Koss is often cited by papers focused on HIV/AIDS Research and Interventions (29 papers), HIV Research and Treatment (16 papers) and HIV, Drug Use, Sexual Risk (12 papers). Catherine A. Koss collaborates with scholars based in United States, Uganda and Kenya. Catherine A. Koss's co-authors include Moses R. Kamya, Monica Gandhi, Diane V. Havlir, Edwin D. Charlebois, Peter Bacchetti, Tamara D. Clark, Howard Horng, Alexander Louie, Paul Natureeba and Deborah Cohan and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Catherine A. Koss

38 papers receiving 985 citations

Peers

Catherine A. Koss
Patrick Coffié Ivory Coast
Nyaradzo Mgodi United States
Nonhlanhla Yende‐Zuma South Africa
Nimâ Machouf Canada
Davies Kimanga Kenya
John Idoko Nigeria
Patrick Ndase United States
Kimberly Struble United States
Sanay Chearskul Thailand
Catherine C. McGowan United States
Patrick Coffié Ivory Coast
Catherine A. Koss
Citations per year, relative to Catherine A. Koss Catherine A. Koss (= 1×) peers Patrick Coffié

Countries citing papers authored by Catherine A. Koss

Since Specialization
Citations

This map shows the geographic impact of Catherine A. Koss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Koss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Koss more than expected).

Fields of papers citing papers by Catherine A. Koss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. Koss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Koss. The network helps show where Catherine A. Koss may publish in the future.

Co-authorship network of co-authors of Catherine A. Koss

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine A. Koss. A scholar is included among the top collaborators of Catherine A. Koss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine A. Koss. Catherine A. Koss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kabami, Jane, Catherine A. Koss, Jaffer Okiring, et al.. (2025). A Peer-Mother Counseling Intervention Improves Early Infant HIV Testing in Rural Uganda. The Pediatric Infectious Disease Journal. 44(11). 1059–1065. 1 indexed citations
2.
Gandhi, Monica, Lucas Hill, Janet Grochowski, et al.. (2024). Case Series of People With HIV on the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial. Open Forum Infectious Diseases. 11(4). ofae125–ofae125. 22 indexed citations
3.
Koss, Catherine A. & Urvi M. Parikh. (2024). Long-acting preexposure prophylaxis: early data on roll-out in the United States. Current Opinion in HIV and AIDS. 20(1). 25–31. 3 indexed citations
4.
Kamya, Moses R., Laura B. Balzer, James Ayieko, et al.. (2024). Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension. The Lancet HIV. 11(11). e736–e745. 15 indexed citations
5.
Kabami, Jane, Elijah Kakande, Gabriel Chamie, et al.. (2023). Uptake of a patient‐centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE study. Journal of the International AIDS Society. 26(S1). e26121–e26121. 11 indexed citations
6.
Parikh, Urvi M., Catherine A. Koss, & John W. Mellors. (2022). Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?. Current HIV/AIDS Reports. 19(5). 384–393. 21 indexed citations
7.
Ayieko, James, Maya L. Petersen, Jane Kabami, et al.. (2021). Uptake and outcomes of a novel community‐based HIV post‐exposure prophylaxis (PEP) programme in rural Kenya and Uganda. Journal of the International AIDS Society. 24(6). e25670–e25670. 21 indexed citations
8.
Balzer, Laura B., Diane V. Havlir, Moses R. Kamya, et al.. (2019). Machine Learning to Identify Persons at High-Risk of Human Immunodeficiency Virus Acquisition in Rural Kenya and Uganda. Clinical Infectious Diseases. 71(9). 2326–2333. 56 indexed citations
9.
Riley, Elise D., Eric Vittinghoff, Catherine A. Koss, et al.. (2019). Housing First: Unsuppressed Viral Load Among Women Living with HIV in San Francisco. AIDS and Behavior. 23(9). 2326–2336. 30 indexed citations
10.
Koss, Catherine A., James Ayieko, Florence Mwangwa, et al.. (2018). Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda. Clinical Infectious Diseases. 67(12). 1853–1860. 23 indexed citations
11.
Koss, Catherine A., Albert Liu, José Castillo‐Mancilla, et al.. (2018). Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine. AIDS. 32(15). 2189–2194. 13 indexed citations
12.
Koss, Catherine A., Peter Bacchetti, Sharon L. Hillier, et al.. (2017). Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. AIDS Research and Human Retroviruses. 33(8). 778–783. 50 indexed citations
13.
Gandhi, Monica, Pamela M. Murnane, Peter Bacchetti, et al.. (2017). Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen. AIDS. 31(16). 2245–2251. 47 indexed citations
14.
Gerona, Roy, Aaron Chin, Catherine A. Koss, et al.. (2016). Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis. PLoS ONE. 11(5). e0155887–e0155887. 16 indexed citations
15.
Koss, Catherine A., Paul Natureeba, Julia Mwesigwa, et al.. (2015). Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women. AIDS. 29(7). 825–830. 49 indexed citations
16.
Koss, Catherine A., Paul Natureeba, Albert Plenty, et al.. (2015). Brief Report. JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(3). 310–315. 18 indexed citations
17.
Cohan, Deborah, Paul Natureeba, Catherine A. Koss, et al.. (2014). Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women. AIDS. 29(2). 183–191. 42 indexed citations
18.
Koss, Catherine A., Paul Natureeba, Albert Plenty, et al.. (2014). Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(2). 128–135. 41 indexed citations
19.
Koss, Catherine A., Eileen F. Dunne, & Lee Warner. (2009). A Systematic Review of Epidemiologic Studies Assessing Condom Use and Risk of Syphilis. Sexually Transmitted Diseases. 36(7). 401–405. 38 indexed citations
20.
Huskamp, Haiden A., Julie M. Donohue, Catherine A. Koss, Ernst R. Berndt, & Richard G. Frank. (2008). Generic Entry, Reformulations and Promotion of SSRIs in the US. PharmacoEconomics. 26(7). 603–616. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Coffié Breakdown of academic impact, for papers by Nyaradzo Mgodi Breakdown of academic impact, for papers by Nonhlanhla Yende‐Zuma Breakdown of academic impact, for papers by Nimâ Machouf Breakdown of academic impact, for papers by Davies Kimanga Breakdown of academic impact, for papers by John Idoko Breakdown of academic impact, for papers by Patrick Ndase Breakdown of academic impact, for papers by Kimberly Struble Breakdown of academic impact, for papers by Sanay Chearskul Breakdown of academic impact, for papers by Catherine C. McGowan
Rankless by CCL
2026